Abiraterone Acetate for Castrate Resistant Prostate Cancer

NCT01961843 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Abiraterone
DRUG: Prednisone

Sponsor

Massachusetts General Hospital